Getting your yearly flu vaccine is essential to prevent illness during cold and flu season. But if you’re not a fan of ...
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...
On September 20, 2024, the U.S. Food & Drug Administration (FDA) announced they had approved an at-home nasal spray influenza ...
People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can ...
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
FluMist (influenza vaccine live, intranasal) is a vaccine used to help prevent flu. FluMist can cause side effects that range from mild to serious. Examples include runny nose, congestion ...